(MRNA) Moderna - Performance -72.1% in 12m
MRNA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-59.31%
#84 in Peer-Group
Rel. Strength
4.30%
#7366 in Stock-Universe
Total Return 12m
-72.06%
#163 in Peer-Group
Total Return 5y
-48.03%
#59 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 32.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 125.14 USD |
| 52 Week Low | 23.65 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 94.60 |
| Buy/Sell Signal +-5 | 2.04 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MRNA (-72.1%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MRNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MRNA
| Total Return (including Dividends) | MRNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.64% | 0.53% | 3.75% |
| 3 Months | 32.06% | 21.37% | 25.32% |
| 12 Months | -72.06% | -9.11% | 13.11% |
| 5 Years | -48.03% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | MRNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 43.4% | -5.7% | 80.3% |
| 3 Months | 43.2% | 79.4% | 97.2% |
| 12 Months | -95.8% | -86.9% | 45.4% |
| 5 Years | -57% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th87.00 | 15.03% | 11.45% |
| 3 Month | %th58.50 | 8.81% | 5.38% |
| 12 Month | %th19.00 | -69.26% | -75.30% |
| 5 Years | %th71.50 | -29.77% | -75.23% |
FAQs
Does Moderna (MRNA) outperform the market?
No,
over the last 12 months MRNA made -72.06%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months MRNA made 32.06%, while XBI made 21.37%.
Performance Comparison MRNA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MRNA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 13% | 11.9% | -30.5% | -85% |
| US NASDAQ 100 | QQQ | 12.4% | 11.5% | -32.1% | -84% |
| German DAX 40 | DAX | 11.1% | 15.4% | -43.3% | -102% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 11.9% | 11.9% | -34.2% | -94% |
| Hongkong Hang Seng | HSI | 13.4% | 12.6% | -51% | -111% |
| India NIFTY 50 | INDA | 13.7% | 14.8% | -31% | -71% |
| Brasil Bovespa | EWZ | 13.7% | 9.8% | -52.5% | -80% |
MRNA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 14.3% | 12.1% | -35% | -96% |
| Consumer Discretionary | XLY | 13.7% | 13.7% | -22.7% | -88% |
| Consumer Staples | XLP | 14.2% | 15.2% | -31% | -80% |
| Energy | XLE | 9.9% | 8.9% | -26.8% | -74% |
| Financial | XLF | 14.3% | 12.9% | -33.1% | -100% |
| Health Care | XLV | 14.7% | 14.6% | -21.6% | -67% |
| Industrial | XLI | 12.9% | 12.5% | -37.4% | -96% |
| Materials | XLB | 12.1% | 11.9% | -34.1% | -78% |
| Real Estate | XLRE | 14.1% | 15.8% | -29.4% | -84% |
| Technology | XLK | 11.3% | 8.5% | -34.6% | -82% |
| Utilities | XLU | 14.4% | 14.4% | -32.9% | -94% |
| Aerospace & Defense | XAR | 12.3% | 11.9% | -48.7% | -120% |
| Biotech | XBI | 11.5% | 15.1% | -16.4% | -63% |
| Homebuilder | XHB | 14.2% | 9.6% | -22.6% | -75% |
| Retail | XRT | 12.9% | 14.1% | -25.8% | -82% |
MRNA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.3% | 8.83% | -24.2% | -68% |
| Natural Gas | UNG | 15.3% | 26.1% | -11.3% | -66% |
| Gold | GLD | 14.5% | 16.4% | -48.3% | -111% |
| Silver | SLV | 11.7% | 15.9% | -46.1% | -90% |
| Copper | CPER | 6.5% | 5.6% | -50.9% | -90% |
MRNA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 15.8% | 14.6% | -26.8% | -69% |
| iShares High Yield Corp. Bond | HYG | 13.6% | 14.3% | -28.9% | -82% |